Abstract: The present invention provides an ostomy draining conduit comprising a proximal self-expanding internal sealing edge designed to be inserted into a stoma and seal the passage between the conduit's exterior wall and the stoma's interior wall; and a distal external draining edge, as well ostomy draining devices comprising same.

Abstract: The present invention relates to a liposomal formulation containing a therapeutic agent and a process for producing the formulation. The liposomal formulation comprises particular characteristics that enhance uniformity and stability of the formulation. The manufacturing process is a novel process that produces a liposomal formulation of a uniform size with many desirable properties that may be independently controlled. Further, the invention relates to a liposome formulation made in accordance with the manufacturing process.

Abstract: A computerized-method for identification of a particular agent within a contact center that participates in an on-line chat session with a customer is provided. An on-line chat system can receive a request from the customer to initiate the on-line chat session. An invisible identifier can be inserted into a message for the online-chat session that uniquely identifies a particular agent handling the chat.

Abstract: A method for enlarging a screen-capture concatenated into a matrix of multiple different screen-captures during playback of a video recording in a video player application, executed by a processor of a computerized system, may include receiving a video recording of a plurality of screen-captures. The video recording may include metadata with coordinates defining a position or a size of each screen-capture from the plurality of screen-captures in the video recording. A selection may be received from a user using an input device coupled to the computerized system of a screen-capture from the plurality of screen-captures in the video recording to view on a display. The coordinates of the selected screen-capture may be transformed by applying an algorithm based on HTML elements, so as to enlarge the selected screen-capture within a mask container. The enlarged screen-capture in the mask container selected by the user may be displayed on the display.

Abstract: A method for enlarging a video element during playback of a video recording in a video player application, executed by a processor of a computerized system, may include receiving a video recording of a plurality of video elements. The video recording may include metadata with coordinates defining a position or a size of each video element from the plurality of video elements in the video recording. A selection may be received from a user using an input device coupled to the computerized system of a video element from the plurality of video elements in the video recording to view on a display. The coordinates of the selected video element may be transformed by applying an algorithm based on HTML elements, so as to enlarge the selected video element within a mask container. The enlarged video element in the mask container selected by the user may be displayed on the display.

Abstract: The present invention relates to a liposomal formulation containing a therapeutic agent and a process for producing the formulation. The liposomal formulation comprises particular characteristics that enhance uniformity and stability of the formulation. The manufacturing process is a novel process that produces a liposomal formulation of a uniform size with many desirable properties that may be independently controlled. Further, the invention relates to a liposome formulation made in accordance with the manufacturing process.

Abstract: A computerized-method for identification of a particular agent within a contact center that participates in an on-line chat session with a customer is provided. An on-line chat system can receive a request from the customer to initiate the on-line chat session. An invisible identifier can be inserted into a message for the online-chat session that uniquely identifies a particular agent handling the chat.

Abstract: The present invention relates to a liposomal formulation containing a therapeutic agent and a process for producing the formulation. The liposomal formulation comprises particular characteristics that enhance uniformity and stability of the formulation. The manufacturing process is a novel process that produces a liposomal formulation of a uniform size with many desirable properties that may be independently controlled. Further, the invention relates to a liposome formulation made in accordance with the manufacturing process.

Abstract: The present invention relates to a liposomal formulation containing a therapeutic agent and a process for producing the formulation. The liposomal formulation comprises particular characteristics that enhance uniformity and stability of the formulation. The manufacturing process is a novel process that produces a liposomal formulation of a uniform size with many desirable properties that may be independently controlled. Further, the invention relates to a liposome formulation made in accordance with the manufacturing process.

Abstract: The present invention relates to a liposomal formulation containing a therapeutic agent and a process for producing the formulation. The liposomal formulation comprises particular characteristics that enhance uniformity and stability of the formulation. The manufacturing process is a novel process that produces a liposomal formulation of a uniform size with many desirable properties that may be independently controlled. Further, the invention relates to a liposome formulation made in accordance with the manufacturing process.

Abstract: Manufactured hyaluronic acid products are used in numerous surgical applications including viscoelastic supplementation for the treatment of osteoarthritis; however, traditional sterilization techniques result in the breakdown of such high molecular o weight viscoelastic biopolymers and are thus unsuitable. Disclosed are processes for obtaining concentrated sterile solutions of high molecular weight biopolymers such as hyaluronic acid. The processes include filter sterilization with a dilute preparation of the biopolymer, and concentration of the dilute filter sterilized biopolymer by ultrafiltration to a desired concentration.

Abstract: Manufactured hyaluronic acid products are used in numerous surgical applications including viscoelastic supplementation for the treatment of osteoarthritis, however, traditional sterilization techniques result in the breakdown of such high molecular o weight viscoelastic biopolymers and are thus unsuitable. Disclosed are processes for obtaining concentrated sterile solutions of high molecular weight biopolymers such as hyaluronic acid. The processes include filter sterilization with a dilute preparation of the biopolymer, and concentration of the dilute filter sterilized biopolymer by ultrafiltration to a desired concentration.

Abstract: The present invention relates to a liposomal formulation containing a therapeutic agent and a process for producing the formulation. The liposomal formulation comprises particular characteristics that enhance uniformity and stability of the formulation. The manufacturing process is a novel process that produces a liposomal formulation of a uniform size with many desirable properties that may be independently controlled. Further, the invention relates to a liposome formulation made in accordance with the manufacturing process.

Abstract: Manufactured hyaluronic acid products are used in numerous surgical applications including viscoelastic supplementation for the treatment of osteoarthritis, however, traditional sterilization techniques result in the breakdown of such high molecular o weight viscoelastic biopolymers and are thus unsuitable. Disclosed are processes for obtaining concentrated sterile solutions of high molecular weight biopolymers such as hyaluronic acid. The processes include filter sterilization with a dilute preparation of the biopolymer, and concentration of the dilute filter sterilized biopolymer by ultrafiltration to a desired concentration.

Abstract: Manufactured hyaluronic acid products are used in numerous surgical applications including viscoelastic supplementation for the treatment of osteoarthritis, however, traditional sterilization techniques result in the breakdown of such high molecular weight viscoelastic biopolymers and are thus unsuitable. Disclosed are processes for obtaining concentrated sterile solutions of high molecular weight biopolymers such as hyaluronic acid. The processes include filter sterilization with a dilute preparation of the biopolymer, and concentration of the dilute filter sterilized biopolymer by ultrafiltration to a desired concentration.